Genotype-Phenotype Correlation of SMN1 and NAIP Deletions in Korean Patients with Spinal Muscular Atrophy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by progressive muscle weakness and atrophy. Most SMA patients have a homozygous deletion in survival of motor neuron 1 (SMN1) gene, and neuronal apoptosis inhibitory protein (NAIP) gene is considered a phenotype modifier. We investigated the genotype-phenotype correlation of SMN1 and NAIP deletions in Korean SMA patients. Methods Thirty-three patients (12 males and 21 females) treated at the Asan Medical Center between 1999 and 2013 were analyzed retrospectively. The polymerase chain reaction (PCR), restriction-fragment-length polymorphism analysis, and multiplex PCR were used to detect deletions in SMN1 (exons 7 and 8) and NAIP (exons 4 and 5). We reviewed clinical presentations and outcomes and categorized the patients into three clinical types. NAIP deletion-driven differences between the two genotypes were analyzed. Results Deletion analysis identified homozygous deletions of SMN1 exons 7 and 8 in 30 patients (90.9%). Among these, compared with patients without an NAIP deletion, those with an NAIP deletion showed a significantly lower age at symptom onset (1.9±1.7 months vs. 18.4±20.4 months, mean±SD; p=0.007), more frequent type 1 phenotype (6/6 vs. 8/24, p=0.005), and worse outcomes, with early death or a requirement for ventilator support (4/4 vs. 2/12, p=0.008). Conclusions Homozygous deletion in SMN1 and a concurrent NAIP deletion were associated with an early onset, severe hypotonia, and worse outcome in SMA patients. Deletion analysis of NAIP and SMN1 can help to accurately predict prognostic outcomes in SMA.
Abstract
Background and Purpose Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by progressive muscle weakness and atrophy. Most SMA patients have a homozygous deletion in survival of motor neuron 1 (SMN1) gene, and neuronal apoptosis inhibitory protein (NAIP) gene is considered a phenotype modifier. We investigated the genotype-phenotype correlation of SMN1 and NAIP deletions in Korean SMA patients. Methods Thirty-three patients (12 males and 21 females) treated at the Asan Medical Center between 1999 and 2013 were analyzed retrospectively. The polymerase chain reaction (PCR), restriction-fragment-length polymorphism analysis, and multiplex PCR were used to detect deletions in SMN1 (exons 7 and 8) and NAIP (exons 4 and 5). We reviewed clinical presentations and outcomes and categorized the patients into three clinical types. NAIP deletion-driven differences between the two genotypes were analyzed. Results Deletion analysis identified homozygous deletions of SMN1 exons 7 and 8 in 30 patients (90.9%). Among these, compared with patients without an NAIP deletion, those with an NAIP deletion showed a significantly lower age at symptom onset (1.9±1.7 months vs. 18.4±20.4 months, mean±SD; p=0.007), more frequent type 1 phenotype (6/6 vs. 8/24, p=0.005), and worse outcomes, with early death or a requirement for ventilator support (4/4 vs. 2/12, p=0.008). Conclusions Homozygous deletion in SMN1 and a concurrent NAIP deletion were associated with an early onset, severe hypotonia, and worse outcome in SMA patients. Deletion analysis of NAIP and SMN1 can help to accurately predict prognostic outcomes in SMA.
참고문헌 (22)
- Czeizel A, "A hungarian study on Werdnig-Hoffmann disease", J Med Genet, 26, pp.761~763 (1989)
- Prior TW, "Newborn and carrier screening for spinal muscular atrophy", Am J Med Genet A, 152A, pp.1608~1616 (2010)
- Munsat TL, "International SMA consortium meeting. (26-28 June 1992, Bonn, Germany)", Neuromuscul Disord, 2, pp.423~428 (1992)
- Faravelli I, "Spinal muscular atrophy--recent therapeutic advances for an old challenge", Nat Rev Neurol, 11, pp.351~359 (2015)
- Finkel RS, "Observational study of spinal muscular atrophy type I and implications for clinical trials", Neurology, 83, pp.810~817 (2014)
- Kaufmann P, "Observational study of spinal muscular atrophy type 2 and 3:functional outcomes over 1 year", Arch Neurol, 68, pp.779~786 (2011)
- Lefebvre S, "Identification and characterization of a spinal muscular atrophydetermining gene", Cell, 80, pp.155~165 (1995)
- McAndrew PE, "Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number", Am J Hum Genet, 60, pp.1411~1422 (1997)
- Zerres K, "59th ENMC International Workshop: Spinal Muscular Atrophies: recent progress and revised diagnostic criteria 17-19April 1998, Soestduinen, the Netherlands", Neuromuscul Disord, 9, pp.272~278 (1999)
- van der Steege G, "PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy", Lancet, 345, pp.985~986 (1995)
- Roy N, "The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy", Cell, 80, pp.167~178 (1995)
- Roberts DF, "The genetic component in child mortality", Arch Dis Child, 45, pp.33~38 (1970)
- Pellizzoni L, "Chaperoning ribonucleoprotein biogenesis in health and disease", EMBO Rep, 8, pp.340~345 (2007)
- Lorson CL, "A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy", Proc Natl Acad Sci U S A, 96, pp.6307~6311 (1999)
- Monani UR, "A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2", Hum Mol Genet, 8, pp.1177~1183 (1999)
- Erdem H, "Deletion analysis in Turkish patients with spinal muscular atrophy", Brain Dev, 21, pp.86~89 (1999)
- Saitoh M, "Correlation between deletion patterns of SMN and NAIP genes and the clinical features of spinal muscular atrophy in Japanese patients", Acta Paediatr Jpn, 39, pp.584~589 (1997)
- Watihayati MS, "Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy", Brain Dev, 31, pp.42~45 (2009)
- Shin S, "Deletion of SMN and NAIP genes in Korean patients with spinal muscular atrophy", J Korean Med Sci, 15, pp.93~98 (2000)
- Cho K, "Correlation between genotype and phenotype in Korean patients with spinal muscular atrophy", Mol Cells, 11, pp.21~27 (2001)
- Fang P, "Molecular characterization and copy number of SMN1, SMN2 and NAIP in Chinese patients with spinal muscular atrophy and unrelated healthy controls", BMC Musculoskelet Disord, 16, pp.11~ (2015)
- Qu YJ, "Association of copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein gene with the natural history in a Chinese spinal muscular atrophy cohort", J Child Neurol, 30, pp.429~436 (2015)